These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2384271)

  • 1. A model-based analysis of the HIP project for breast cancer screening.
    van Oortmarssen GJ; Habbema JD; Lubbe JT; van der Maas PJ
    Int J Cancer; 1990 Aug; 46(2):207-13. PubMed ID: 2384271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation risk of mammography related to benefit in screening programmes: a favourable balance?
    Beemsterboer PM; Warmerdam PG; Boer R; de Koning HJ
    J Med Screen; 1998; 5(2):81-7. PubMed ID: 9718526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for breast cancer screening.
    van Oortmarssen GJ; Habbema JD; van der Maas PJ; de Koning HJ; Collette HJ; Verbeek AL; Geerts AT; Lubbe KT
    Cancer; 1990 Oct; 66(7):1601-12. PubMed ID: 2119877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.
    Humphrey LL; Helfand M; Chan BK; Woolf SH
    Ann Intern Med; 2002 Sep; 137(5 Part 1):347-60. PubMed ID: 12204020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan.
    Shapiro S
    J Natl Cancer Inst Monogr; 1997; (22):27-30. PubMed ID: 9709271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
    Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
    Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project.
    Smart CR
    Cancer; 1994 Jul; 74(1 Suppl):296-300. PubMed ID: 8004600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Canadian National Breast Screening Study: a perspective on criticisms.
    Baines CJ
    Ann Intern Med; 1994 Feb; 120(4):326-34. PubMed ID: 8291826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations.
    Shen Y; Zelen M
    J Clin Oncol; 2001 Aug; 19(15):3490-9. PubMed ID: 11481355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer. Early detection may mean cure.
    Bertrand ML; Hayes AL
    N C Med J; 1993 Jan; 54(1):25-8. PubMed ID: 8426659
    [No Abstract]   [Full Text] [Related]  

  • 14. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening.
    Shapiro S; Venet W; Strax P; Venet L; Roeser R
    Natl Cancer Inst Monogr; 1985 May; 67():65-74. PubMed ID: 4047153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.
    Miller AB; To T; Baines CJ; Wall C
    Ann Intern Med; 2002 Sep; 137(5 Part 1):305-12. PubMed ID: 12204013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.
    Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R
    J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.
    Brekelmans CT; Westers P; Faber JA; Peeters PH; Collette HJ
    J Epidemiol Community Health; 1996 Feb; 50(1):68-71. PubMed ID: 8762357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of mass screening for breast cancer in Japan.
    Okubo I; Glick H; Frumkin H; Eisenberg JM
    Cancer; 1991 Apr; 67(8):2021-9. PubMed ID: 1900734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the sensitivity of breast cancer screening--experience with the Honolulu BCDDP data.
    Grove JS; Goodman MJ; Gilbert FI; Low G
    Breast Cancer Res Treat; 1991 May; 18 Suppl 1():S97-101. PubMed ID: 1873566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.